Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program

April 25, 2024

Read More email

APDN Announces Publication of Peer-Reviewed Journal Article Validating Potential Use of linearDNA™ as a New Class of DNA-Based Vaccines

January 5, 2023

Read More email

Applied DNA and Evvivax Initiate Phase I of Clinical Trial to Evaluate LinearDNA™ COVID-19 Vaccine Candidate for Feline Veterinary Market

March 2, 2021

Read More email